These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9583603)
1. Maximum impact of HIV prevention measures targeted at injecting drug users. van Ameijden EJ; Coutinho RA AIDS; 1998 Apr; 12(6):625-33. PubMed ID: 9583603 [TBL] [Abstract][Full Text] [Related]
2. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. Lindenburg CE; Krol A; Smit C; Buster MC; Coutinho RA; Prins M AIDS; 2006 Aug; 20(13):1771-5. PubMed ID: 16931942 [TBL] [Abstract][Full Text] [Related]
3. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. Strathdee SA; Patrick DM; Currie SL; Cornelisse PG; Rekart ML; Montaner JS; Schechter MT; O'Shaughnessy MV AIDS; 1997 Jul; 11(8):F59-65. PubMed ID: 9223727 [TBL] [Abstract][Full Text] [Related]
4. Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. Van Ameijden EJ; Langendam MW; Notenboom J; Coutinho RA Addiction; 1999 Jul; 94(7):1051-61. PubMed ID: 10707443 [TBL] [Abstract][Full Text] [Related]
5. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124 [TBL] [Abstract][Full Text] [Related]
6. Operating needle exchange programmes in the hills of Thailand. Gray J AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363 [TBL] [Abstract][Full Text] [Related]
7. Young and recent-onset injecting drug users are at higher risk for HIV. Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489 [TBL] [Abstract][Full Text] [Related]
8. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379 [TBL] [Abstract][Full Text] [Related]
10. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. Schechter MT; Strathdee SA; Cornelisse PG; Currie S; Patrick DM; Rekart ML; O'Shaughnessy MV AIDS; 1999 Apr; 13(6):F45-51. PubMed ID: 10397556 [TBL] [Abstract][Full Text] [Related]
11. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Schlumberger MG; Desenclos JC; Papaevangelou G; Richardson SC; Ancelle-Park R Eur J Epidemiol; 1999 Mar; 15(3):207-15. PubMed ID: 10395049 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users. Baker A; Heather N; Wodak A; Dixon J; Holt P AIDS; 1993 Feb; 7(2):247-56. PubMed ID: 8466688 [TBL] [Abstract][Full Text] [Related]
13. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. van Ameijden EJ; Coutinho RA J Epidemiol Community Health; 2001 May; 55(5):356-63. PubMed ID: 11297661 [TBL] [Abstract][Full Text] [Related]
14. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? Wood E; Tyndall MW; Spittal PM; Li K; Kerr T; Hogg RS; Montaner JS; O'Shaughnessy MV; Schechter MT CMAJ; 2001 Aug; 165(4):405-10. PubMed ID: 11531048 [TBL] [Abstract][Full Text] [Related]
15. Needle exchange use among a cohort of injecting drug users. Schoenbaum EE; Hartel DM; Gourevitch MN AIDS; 1996 Dec; 10(14):1729-34. PubMed ID: 8970694 [TBL] [Abstract][Full Text] [Related]
16. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Murray JM; Law MG; Gao Z; Kaldor JM Int J Epidemiol; 2003 Oct; 32(5):708-14. PubMed ID: 14559736 [TBL] [Abstract][Full Text] [Related]
17. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064 [TBL] [Abstract][Full Text] [Related]
18. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M; Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278 [TBL] [Abstract][Full Text] [Related]
19. A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden. Karlsson N; Kåberg M; Berglund T; Hammarberg A; Widman L; Ekström AM Int J Drug Policy; 2021 Apr; 90():103059. PubMed ID: 33360734 [TBL] [Abstract][Full Text] [Related]
20. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. Uusküla A; Kals M; Rajaleid K; Abel K; Talu A; Rüütel K; Platt L; Rhodes T; Dehovitz J; Des Jarlais D J Public Health (Oxf); 2008 Jun; 30(2):119-25. PubMed ID: 18308743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]